I have had several patients ask me whether or not they should get the swine flu (H1N1) vaccine. My response has been the same. I will not be getting the vaccine because I don’t think it is safe.
I am an MD who was trained to practice medicine the old fashioned way. My education was based on understanding and treating disease. As a surgeon, I was taught that in some cases surgical correction is the most efficient and expedient way to fix a problem or cure a disease. In short, I have a healthy respect for the standard medical care that is practiced in this country.
However, over the past 10 years since I have been in practice, I have seen a disturbing trend that has become increasingly more common. Although we have the most advanced medical system in the world, the best trained physicians, and access to new and ever evolving medications, we as a nation and particularly the minority population are getting sicker at a younger age, and our quality of life is suffering. There are more people suffering from depression, anxiety, and learning disabilities than at any time in our history. Unfortunately, we have learned to manage diseases by taking a pill everyday instead of doing what it takes to prevent the illness in the first place. It is past time to look to good nutrition and prevention as a means of preventing and curing chronic diseases such as diabetes, hypertension, obesity and some cancers which have risen to epidemic levels.
When I made the personal decision to ask questions about the Swine flu vaccine, the answers that I discovered contradicted the mantra that has been championed by the media, government officials, and the vaccine manufacturers. What we are being told simply does not make any sense. The most important question that I have learned to ask (from the politics of healthcare to every other facet of our society that affects us as individuals) is - who stands to gain?
I will not be getting the swine flu vaccine because:
- The vaccine makers have been given immunity from being sued for any bad outcome
After the deaths and injuries associated with the Swine flu vaccination campaign in 1976, the vaccine manufacturers lost billions of dollars in civil suits. That cannot happen this time around. Congress has since passed two bills that shield vaccine makers from civil suits. The first in 1986 protects vaccine makers from civil suits filed by people who have been injured by a vaccine due to ‘unavoidable side effects’. In 2006 another iteration of the shield law (The Epidemic Preparedness Act) was passed as part of the Patriot Act and extends the shield to include protection if the drug maker has ‘no willful knowledge’ that a vaccine may cause injury. In short, a maker of the Swine flu vaccine simply has to say they didn’t know the vaccine was going to cause harm then they cannot be sued. This won’t be hard to do since they have not fully tested the vaccine.
- There are many ingredients in vaccines called adjuvants that are put in to stimulate the immune response
Vaccines work by stimulating the immune system to make cells called antibodies. Once formed antibodies will theoretically protect someone from getting the illness. In short, disease is prevented because the antibodies activate and short circuit an attack. There have been many adjuvants used. They include: spermacides, antifreeze, aluminum, mercury (thiamerosol) and Squalene. The problem with adjuvants is that they can stimulate the body’s immune system to attack itself. These sorts of diseases are classified as autoimmune diseases.
- Studies that report that vaccines (such as the Swine flu vaccine and other Vaccines like Gardasil) are safe are largely sponsored by Big Pharma
Many studies have been performed under the auspices of pharmaceutical companies. Vioxx is one glaring examples of a pharmaceutical company rigging the scientific results to bring a product to market and keeping it there despite clinical evidence of its danger in the name of profit. The most recent examples are studies looking at the safety of Squalene (MF59) in the swine flu vaccine which have been sponsored by pharmaceutical companies like Novartis .
- Mercury is one of the adjuvants used in the new Swine Flu vaccine.
There is a question about whether it plays a role in causing autism. One study found an increase in mercury in the urine of children with autism and none in children without autism. Although no definitive answer has yet been found to unequivocally tie mercury to autism, there is still cause for concern in giving the thiamerosol to pregnant women and to children as mercury is known to be neurotoxic. In addition, studies have found a weak link between thiamerosol and neurodevelopmental disorders such as attention deficit and hyperactivity disorder (ADHD). The FDA and CDC have recommended that thiamerosol be reduced and/or removed from childhood vaccines for enhanced safety.
- Some of the manufactures outside the US are using Squalene which is a known neurotoxin
Squalene is a type of fat found in foods like olive oil. When it is eaten it actually has benefits as an antioxidant. However, when it enters the blood stream through an injection it can trigger an autoimmune response by inciting the immune system to attack all ‘squalene containing’ structures in the body. The highest concentration is in the nervous system because nerves are wrapped in a sheath that is made in part of squalene. When these cells are attacked, it can damage the neurological system. In fact, studies have linked the nerve damage of soldiers affected with the Gulf War Syndrome (GWS) with the squalene that was present in the Anthrax vaccine that they were given. Soldiers who developed neurological symptoms and chronic pain associated with GWS had received the vaccine, while the soldiers who did not receive the vaccine had no complaints. It technically has not been licensed in the US, but the fast tracking of the vaccine has left the question of whether squalene is present in some of the vaccines dispensed unanswered.
- Aluminum has been linked to Alzheimer’s disease and inflammatory conditions such as heart disease
Aluminum is an adjuvant present in vaccines.
- A live-attenuated virus is being offered that could increase the risk of Guillain-Barre as well as the spread of the virus.
The nasal form of the vaccine contains live virus that has been weakened. Why has this form of the virus been sent to the market first, when the HHS and CDC have advocated that people with chronic disease, weakened immune systems, children and pregnant woman be the first groups to receive the vaccine? Not only do these patients have the highest risk of getting the disease because of their weakened immune system, they can easily become vectors for the disease since they are capable of infecting anyone they are in contact with for up to 21 days after they receive the vaccine. This has the potential to spread the disease exponentially thereby fulfilling the prophecy of the pandemic.
There are some who should not take the vaccine (neither the injectable nor the nasal version) because the risks of side effects strongly out weigh the benefits. They include 1.) individuals who have had Gullain-Barre Syndrome in the past; 2) those with chronic inflammatory diseases; 3) those with full-blown AIDs; 4) individuals on chemotherapy with a suppressed white count; 5) children under 6 months of age; and 7) those on immunosuppressant drugs post organ transplant.
Dr Elaina George is Board certified Otolaryngologist who started Peachtree ENT Center with a mission to practice state of the art medicine that is available to everyone. She graduated from Princeton University with a degree in Biology. She received her Masters degree in Medical Microbiology at Long Island University, and received her medical degree from Mount Sinai School of Medicine in New York. Dr George completed her residency at Manhattan, Eye Ear & Throat Hospital. Her training included general surgery at Lenox Hill Hospital, pediatric ENT at The NY-Presbyterian Hospital, and head and neck oncology at Memorial Sloan-Kettering Cancer Center. She has published in several scientific journals and presented her research at national meetings.
For media or speaking requests, please call (901) 413-0203 or email@example.com